MindImmune Therapeutics: Funding, Investors & Team (Sep 2026)
MindImmune Therapeutics is a pharmaceutical company developing drugs to treat diseases of the central nervous system.
MindImmune Therapeutics has raised $15.2M across 2 funding rounds on record, the most recent an undisclosed round of $5.0M announced in Mar 2026.
That round is below the $7.5M median round size for United States companies tracked on FundedIQ over the last two years.
MindImmune Therapeutics Company Profile and Key Stats
Latest funding round on record: Mar 2026.
MindImmune Therapeutics Funding Rounds
MindImmune Therapeutics raised $10.2M in a Series A announced in Nov 2025.
4 months later, an undisclosed round of $5.0M was announced in Mar 2026.
MindImmune Therapeutics Founders and Leadership Team
Contact details for the MindImmune Therapeutics team: 1 of 3 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →MindImmune Therapeutics Funding in Context
MindImmune Therapeutics' latest round of $5.0M is below the median round in United States. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like MindImmune Therapeutics in Pharmaceuticals and Kingston
Companies Similar to MindImmune Therapeutics
Avanzanite Bioscience enhances access to orphan drugs in Europe, partnering with pharma for rare disease…
Jianersheng Pharmaceutical is a manufacturer of heavy metal detoxification drugs.
ProFound Therapeutics is creating profound impacts on the understanding of biology and disease and the…
A multi-format private capital intelligence platform.
TRAXyL invented a new way to install broadband communications by essentially "painting" optical fiber…
Electric Pickle features pickleball courts, outdoor entertainment, and a restaurant with globally inspired…
Atorie is an online platform connecting luxury factories with customers that handles everything from…
Platform Therapeutics develops therapies for chemotherapy toxicities and dialysis-related muscle cramps.
NantOptiFab builds advanced photonic chips and wafers for telecom, AI, defense, and quantum applications.
Babynetic is a baby gear company creating stylish, safe, innovative products using patented magnetic designs…
Phyll uses AI and existing cameras to monitor infrastructure assets, detect changes, and deliver real-time…
Mendara Energy develops off-grid renewable power campuses that provide reliable, scalable energy for AI and…
MindImmune Therapeutics Funding FAQs
What does MindImmune Therapeutics do?
MindImmune Therapeutics is a pharmaceutical company developing drugs to treat diseases of the central nervous system.
How much funding has MindImmune Therapeutics raised?
MindImmune Therapeutics has raised $15.2M across 2 rounds on record. The most recent is an undisclosed round of $5.0M announced in Mar 2026.
When did MindImmune Therapeutics last raise funding?
MindImmune Therapeutics' most recent funding round on record is an undisclosed round of $5.0M, announced in Mar 2026.
Who founded MindImmune Therapeutics?
FundedIQ lists Frank S Menniti (Founder), Stevin Zorn (Founder) at MindImmune Therapeutics.
Where is MindImmune Therapeutics headquartered?
MindImmune Therapeutics is based in Kingston, United States.
How many employees does MindImmune Therapeutics have?
MindImmune Therapeutics is in the 1-10 employee band.
About FundedIQ's MindImmune Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for MindImmune Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.